Reuters -- Ondine Biopharma Corp agreed to buy closely held Advanced Photodynamic Technologies Inc for about C$575,670 ($551,300) in stock to expand its product portfolio, sending shares of the Canadian biotechnology company up 18 percent.
Reuters -- Ondine Biopharma Corp agreed to buy closely held Advanced Photodynamic Technologies Inc for about C$575,670 ($551,300) in stock to expand its product portfolio, sending shares of the Canadian biotechnology company up 18 percent.
